350
Participants
Start Date
July 17, 2024
Primary Completion Date
May 31, 2026
Study Completion Date
June 30, 2026
Lumateperone
Lumateperone 42 mg capsules administered orally, once daily
Placebo
Matching capsules administered orally, once daily
RECRUITING
Clinical Site, Sofia
RECRUITING
Clinical Site, Plovdiv
RECRUITING
Clinical Site, Kazanlak
RECRUITING
Clinical Site, Burgas
RECRUITING
Clinical Site, Sliven
RECRUITING
Clinical Site, Belgrade
NOT_YET_RECRUITING
Clinical Site, Glen Oaks
RECRUITING
Clinical Site, Gaithersburg
RECRUITING
Clinical Site, Kovin
RECRUITING
Clinical Site, Stockbridge
RECRUITING
Clinical Site, Atlanta
RECRUITING
Clinical Site, Hialeah
RECRUITING
Clinical Site, Miami Lakes
RECRUITING
Clinical Site, Miami Lakes
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, West Palm Beach
RECRUITING
Clinical Site, Tampa
RECRUITING
Clinical Site, Kragujevac
NOT_YET_RECRUITING
Clinical Site, Cincinnati
RECRUITING
Clinical Site, Chicago
RECRUITING
Clinical Site, Chicago
RECRUITING
Clinical Site, Little Rock
RECRUITING
Clinical Site, Bentonville
RECRUITING
Clinical Site, Richardson
RECRUITING
Clinical Site, Torrance
RECRUITING
Clinical Site, Cerritos
RECRUITING
Clinical Site, Anaheim
RECRUITING
Clinical Site, Orange
RECRUITING
Clinical Site, Brasov
RECRUITING
Clinical Site, Iași
RECRUITING
Clinical Site, Bucharest
RECRUITING
Clinical Site, Niš
RECRUITING
Clinical Site, Novi Kneževac
Lead Sponsor
Intra-Cellular Therapies, Inc.
INDUSTRY